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Scheme 1. Retrosynthetic Scheme 
Scheme 3.  Attempts to synthesize  sp2 C-7 analogues
Scheme 2. General synthetic scheme of Hyperforin’s analogues
Hyperforin, the most known member of this family, has been isolated from Hypericum perforatum (St. Johns’s wort), known for its antidepressant and 
anticancer properties.  There is a big interest in synthesizing Hyperforin’s analogues in order to improve the molecule’s activity.[1,3] Up-to-date analogues showing 
highest biological activity possess an enol hydroxyl free [3g-i]. Based on this literature background, our efforts focus on the design and synthesis of new analogues with 
improved properties.  In our lab, a new short biomimetic approach has been developed leading to the fully functionalized bicyclic core of type A acylphloroglucinols, 
including Hyperforin.[2] Based on this strategy we targeted in two classes of compounds possessing either an sp2- or an sp3-carbon on C-7, starting from key 
intermediate 1 (Scheme 1).   A general route leading to 1 is depicted on Scheme 2.  Approaches to sp2 C-7 analogues including either Wittig on Ac-1 (Approach I, 
Scheme 3) or deprotection after Wittig on Pv-1 led to no desirable results (Approach II).  Thus, approach III was attempted, based on establishing the desirable side 
chain functionalization before alkylation step.   It is interesting that attempting to saturate C-7 of compound  1,  via Michael addition ,  an unprecedented  skeletal 
rearrangement  to  a 6,5-bicyclic ring system was observed.  Thus, deacetylation of aldehyde Ac-1, led to analogue 2, which after Michael  afforded sp3 C-7 analogue 3 
(Scheme 4), whose structure was confirmed by X-ray analysis .  Derivatives  4 and  5  were  also prepared.  Biological activity results obtained from our first 
derivatives will lead our design to a new generation of hyperforin analogues.  Moreover, our efforts focus on the improvement of efficiency of our methodology.
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